Related Experiment Video
Updated: Jun 9, 2025
09:04
Low-Cost Single-Port LoCoSP Device for a Transcervical Approach in Minimally Invasive Transhiatal Esophagectomy
Published on: September 11, 2021
2.8K
Minimally Invasive Transhiatal Esophagectomy Using Antegrade Inversion Technique in Esophageal Cancer: 10-Year
Thitiporn Chobarporn1, Alia Qureshi2, John G Hunter2
1Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A
|October 23, 2024
Summary
Minimally invasive transhiatal esophagectomy (MI-THE) shows promise for esophageal cancer, especially in early stages. This technique demonstrated safety and feasibility with no mortality, though complications like pleural effusion occurred.
Area of Science:
- Surgical Oncology
- Gastrointestinal Surgery
- Minimally Invasive Procedures
Background:
- Esophageal cancer surgery aims for cure but has high complication rates.
- Transthoracic esophagectomy is standard, but transhiatal esophagectomy (THE) has specific advantages.
- Minimally invasive THE (MI-THE) is emerging, with limited data on its outcomes.
Purpose of the Study:
- To evaluate the safety and perioperative outcomes of minimally invasive transhiatal esophagectomy (MI-THE).
- To assess the feasibility of the "Antegrade Inversion Technique" for MI-THE.
- To identify complications associated with MI-THE in esophageal cancer patients.
Main Methods:
- Retrospective review of 38 esophageal cancer patients undergoing MI-THE.
- Analysis of perioperative outcomes including operative time, hospital and ICU stay.
- Data collected between 2013 and 2023 at a tertiary care center.
Main Results:
- Median operative time: 375 minutes; median hospital stay: 8 days; median ICU stay: 3 days.
- Negative resection margins achieved in all patients.
- Most common complications: pleural effusion (57.9%), pneumothorax (31.6%), surgical site infection (15.8%); anastomotic leak rate: 13.2%; no mortality.
Conclusions:
- MI-THE is a safe and feasible option for esophageal cancer, particularly for early-stage disease.
- The "Antegrade Inversion Technique" shows encouraging perioperative results.
- Further research is needed to compare MI-THE with traditional open approaches.
